Daily News header

Burzynski Film Review

By     get stories by email

Cancer Researcher: Total Quack or Medical Pioneer?

In the 1970s, Dr. Stanislaw Burzynski discovered Antineoplastons, a family of pharmaceuticals which soon met with amazing success in treating cancer patients. One would think that the phenomenal results of the M.D./Ph.D.'s oncological research would be eagerly embraced by both the medical and drug manufacturing communities in the wake of such a groundbreaking discovery.

Unfortunately, this was not the case, ostensibly because cancer is big business, and there are billions of dollars to be made in its treatment. So, even though Dr. Burzynski's life-saving, alternative gene therapy had better survival rates than conventional treatment with chemotherapy, surgery and/or radiation, he found himself ostracized by his colleagues and accused of being a quack by everyone from the National Cancer Institute to the Food and Drug Administration (FDA).

Consequently, by 1995, he found himself charged with 75 counts of fraud which imperiled his practice and liberty, since he could have ended up in prison and saddled with $18 million in fines. Ironically, while Burzynski's time was then consumed with defending himself in a 14-year legal battle, competitors filed copycat patents in an effort to take credit for his miraculous discovery.

Is Dr. Stanislaw Burzynski a shameless charlatan or a genius being denied his rightful recognition for coming up with a non-toxic cure? This is the issue addressed by Burzynski, an eye-opening expose' by Eric Merola. Mr. Merola makes a most-impressive directorial debut with this documentary featuring offsetting testimonials by his grateful patients with ones by avaricious detractors perhaps hiding financial agendas.

So, what's the truth? This critic is not inclined to draw scientific conclusions based on a movie which might be biased. Suffice to say that the jurors who heard the expert testimony and examined all the evidence at Burzynski's trial are pretty persuasive when they call the FDA's case against him little more than a witch hunt.

A bio-pic of Biblical proportions featuring a showdown of Dr. David versus a government Goliath!

Excellent (4 stars)
Unrated
Running time: 106 Minutes
Distributor: Cinema Village
To see a trailer for Burzynski, press play:

Kam Williams is a syndicated film and book critic who writes for 100+ publications. He is a member of the New York Film Critics Online, the African-American Film Critics Association, and the NAACP Image Awards Nominating Committee. Contact him through NewsBlaze.

  Please click this get stories by email button to be notified about future stories, and please leave a comment below.

  Please leave a comment here     If it does not display within 10 seconds, please refresh the page

Related Movie Reviews News

Chef, author, world traveler Anthony Bourdain is an outspoken trailblazer with unique insights talks about his life, career and Peabody and Emmy-winning TV-series, Parts Unknown.
Kam Williams interviews Gina the Dreamer about Beyond the Lights, a romance drama co-starring Gugu Mbata-Raw and Nate Parker.
Marion Cotillard, who is no stranger to tackling complex characters and complicated women in movies, most notably as Edith Piaf in La Vie En Rose, plays Sandra in Two Days, One Night. An emotionally vulnerable blue collar worker in a plant determine
Stevie Nicks, older and ever bolder turned heads with Stevie's back-to-the-future, pre-technoid selfies at an opening exhibition in the Morrison Hotel Gallery, Manhattan.
Michael Pena, who first appeared in 'To Sir, with Love' and 'End of Watch' director David Ayer talk to Kam Williams about reuniting to collaborate on Fury.
Rosamund Pike stopped by the NY Film Festival where Gone Girl premiered, to weigh in on assorted relevant topics, with Prairie Miller.

 

NewsBlaze Writers Of The Month



Popular Stories This Month

newsletter logo

NewsBlaze
Copyright © 2004-2014 NewsBlaze Pty. Ltd.
Use of this website is subject to our Terms of Service and Privacy Policy  | DMCA Notice               Press Room   |    Visit NewsBlaze Mobile Site